Reviva Pharmaceuticals Holdings, Inc. (RVPH)
RVPH Stock Price Chart
Explore Reviva Pharmaceuticals Holdings, Inc. interactive price chart. Choose custom timeframes to analyze RVPH price movements and trends.
RVPH Company Profile
Discover essential business fundamentals and corporate details for Reviva Pharmaceuticals Holdings, Inc. (RVPH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Oct 2018
Employees
14.00
Website
https://revivapharma.comCEO
Laxminarayan Bhat
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
RVPH Financial Timeline
Browse a chronological timeline of Reviva Pharmaceuticals Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.12.
Earnings released on 14 Aug 2025
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%.
Earnings released on 15 May 2025
EPS came in at -$0.13 surpassing the estimated -$0.21 by +38.10%.
Earnings released on 31 Mar 2025
EPS came in at -$0.15 surpassing the estimated -$0.22 by +31.82%.
Earnings released on 14 Nov 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%.
Earnings released on 14 Aug 2024
EPS came in at -$0.26 surpassing the estimated -$0.28 by +7.14%.
Earnings released on 14 May 2024
EPS came in at -$0.25 surpassing the estimated -$0.28 by +10.71%.
Earnings released on 15 Apr 2024
EPS came in at -$0.35 matching the estimated -$0.35.
Earnings released on 14 Nov 2023
EPS came in at -$0.44 falling short of the estimated -$0.35 by -25.71%.
Earnings released on 14 Aug 2023
EPS came in at -$0.55 falling short of the estimated -$0.29 by -89.66%.
Earnings released on 15 May 2023
EPS came in at -$0.30 surpassing the estimated -$0.36 by +16.67%.
Earnings released on 30 Mar 2023
EPS came in at -$0.38 falling short of the estimated -$0.23 by -65.22%.
Earnings released on 14 Nov 2022
EPS came in at -$0.18 surpassing the estimated -$0.30 by +40.00%.
Earnings released on 15 Aug 2022
EPS came in at -$0.29 surpassing the estimated -$0.31 by +6.45%.
Earnings released on 16 May 2022
EPS came in at -$0.40 falling short of the estimated -$0.28 by -42.86%.
Earnings released on 15 Mar 2022
EPS came in at -$0.24 matching the estimated -$0.24.
Earnings released on 15 Nov 2021
EPS came in at -$0.12 surpassing the estimated -$0.25 by +52.00%.
Earnings released on 16 Aug 2021
EPS came in at -$0.12 surpassing the estimated -$0.24 by +50.00%.
Earnings released on 17 May 2021
EPS came in at -$0.10 .
Earnings released on 22 Mar 2021
EPS came in at -$0.17 falling short of the estimated -$0.06 by -175.12%.
Earnings released on 14 Sept 2020
EPS came in at -$0.24 .
RVPH Stock Performance
Access detailed RVPH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.